Treatment of nonmelanoma skin cancer in organ transplant recipients: review of responses to a survey.
There are approximately 100,000 US organ transplant recipients, many with nonmelanoma skin cancers. To better understand how clinicians treat them, we e-mailed a survey to the International Transplant-Skin Cancer Collaborative and the Association of Academic Dermatologic Surgeons. Twenty-five physicians responded. The majority use topical 5-fluorouracil, cryosurgery, electrodesiccation and curettage, and surgery. We review when these modalities are used.
Clayton
Anna S
AS
Division of Dermatology, Mohs Micrographic Surgery Clinic, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Stasko
Thomas
T
D002280:Basal Cell Carcinoma / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D003452:Cryosurgery / Q000379:methods; D004598:Electrosurgery / Q000379:methods; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D019538:Health Care Surveys; D006801:Humans; D016867:Immunocompromised Host; D015994:Incidence; D008297:Male; D016377:Organ Transplantation; D011379:Prognosis; D018570:Risk Assessment; D012878:Skin Neoplasms / Q000453:epidemiology / Q000473:pathology* / Q000628:therapy*; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
D005472:Fluorouracil